Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nebraska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nebraska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nebraska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jennifer Elliott (NPI 1093823437)

Field	Value
Entity Type	Individual
Organization	Jennifer Elliott
Address	7441 O St Ste 400
City	Lincoln
State	NE
ZIP	68510
Taxonomy	Rheumatology Physician
NPI Enumerated	August 27, 2006

Payer Source	Total Paid
Medicare	$767.9K
Medicaid	$0

Key Findings

This provider’s billing footprint is effectively single‑payer: total Medicare revenue is $767.9K and there is no Medicaid billing on file, so Nebraska Medicaid exposure is negligible. Analysts should treat Medicare as the dominant and only material public-payer revenue source when evaluating network access or utilization for this NPI.

Revenue is highly concentrated in a small set of biologic drug administrations: the precomputed top three Medicare codes account for 70.2% of total Medicare revenue, led by J3111 ($280.6K, 36.1%) and followed by J0717 ($160K, 20.6%) and J3262 ($104.8K, 13.5%). This concentration indicates that a handful of high‑cost injectable biologics drive the bulk of reimbursement for this practice.

The code mix and descriptions point to a rheumatology practice built around in‑office biologic and injectable therapy administration rather than visit volume. High revenues on drug codes such as J3111, J0717, J3262 and supplemental osteoporosis agents like J0897 ($58.3K, 7.5%) align with infusion/subcutaneous injection services and bone‑health management.

Competitive standing varies by drug: J3111 ranks #134 of 970 providers nationally (86th percentile), indicating above‑average national volume for that specific drug, while J0717 (rank #508 of 848, 40th percentile) and J3262 (rank #490 of 618, 21th percentile) are more modest or below‑median contributors compared with peers. Overall this provider is a notable national participant for J3111 but a modest player for other top biologics.

Operationally the provider bills a meaningful set of infusion/administration procedure codes, demonstrating on‑site therapeutic delivery capacity: 96401 appears with $13.5K (1.7%), 96413 with $7.6K (1.0%), and 96365 with $2.8K (0.4%), while the add‑on 96415 and injection code 96372 are present at smaller levels. These entries confirm routine administration of injectable/infusible therapies rather than exclusively prescribing self‑administered drugs.

Evaluation and management services comprise a small portion of revenue relative to drugs: 99214 accounts for $20.8K (2.7%) and 99204 for $11.7K (1.5%), showing that face‑to‑face visit charges are secondary to biologic/drug administration in the revenue mix. Payers and contract analysts should therefore prioritize drug reimbursement, acquisition, and billing oversight over E/M utilization for this NPI.

Tenure is long enough to assess patterns: the NPI was enumerated on 2006-08-27 (approximately 20 years ago), giving a two‑decade claims history that supports trend analysis and peer comparisons. This longevity increases confidence that the observed drug‑heavy billing profile is an established practice pattern rather than a transient anomaly.

Given the lack of Medicaid billing and the fact that J3111 ($280.6K, 36.1%) and J0717 ($160K, 20.6%) are the single largest revenue drivers, payer oversight or contracting conversations should focus on utilization and reimbursement arrangements for those specific injectable biologics. Absent Medicaid activity, state Medicaid network and access issues are unlikely to be materially affected by this provider.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3111	Injection, romosozumab-aqqg, 1 mg	35,070	$10	$280.6K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	40,000	$1	$160K
J3262	Injection, tocilizumab, 1 mg	20,960	$10	$104.8K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	3,180	$30	$101.6K
J0897	Injection, denosumab, 1 mg	3,240	$20	$58.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	240	$90	$20.8K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	250	$50	$13.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	110	$110	$11.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	80	$90	$7.6K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	50	$130	$6K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Nebraska Distribution

Jennifer Elliott — 0 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Nebraska

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	5	10	8,880	$30	$476.1K
J0717	4	10	56,400	$1	$414.5K
J3262	4	10	55,060	$1	$340.9K
J3111	2	10	28,140	$10	$291.3K
J0897	61	200	2,040	$20	$62.7K
96413	41	80	60	$90	$18.2K
99214	877	3,210	110	$70	$14.9K
96401	6	30	120	$50	$11K
99215	368	920	40	$110	$7K
99204	140	1,320	30	$100	$5.3K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jennifer Elliott, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Louisiana State University School Of Med In New Orleans Faculty Grou	LA	Pediatrics Physician	$0	$43M
University Of Pittsburgh Physicians	PA	Psychiatry Physician	$0	$26.4M
University Of Pittsburgh Physicians	PA	Specialist	$0	$23.6M
Ashok Muthukrishnan	FL	Nuclear Radiology Physician	$3.9M	$129.2K
Daniel Delo	NC	Rheumatology Physician	$2.8M	$0
Vimala Ramesh	PA	Anesthesiology Physician	$57.8K	$2.2M
Medical Foundation, Inc.	MS	Geriatric Medicine (Family Medicine) Physician	$0	$1.8M
Pamela Rath	PA	Ophthalmology Physician	$1.7M	$17.7K
Christopher Hodge	MA	Anesthesiology Physician	$109.9K	$1.6M
Charles Luke	PA	Anesthesiology Physician	$59.3K	$1.6M

Nearby Providers

Other providers in the same ZIP code as Jennifer Elliott, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Saint Elizabeth Regional Medical Center	NE	General Acute Care Hospital	$0	$14.9M
St. Monica's	NE	Substance Abuse Rehabilitation Facility	$0	$7.1M
Hopespoke	NE	Community/Behavioral Health Agency	$0	$3.9M
Centerpointe, Inc.	NE	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$3.7M
Bluestem Health	NE	Federally Qualified Health Center (FQHC)	$0	$3.6M
Lincoln Medical Education Partnership	NE	Family Medicine Physician	$0	$3.2M
Hopespoke	NE	Community/Behavioral Health Agency	$0	$2.9M
Lincoln-lancaster County Health Department	NE	Public Health or Welfare Agency	$0	$2.7M
Chi Health Clinic Specialty, LLC	NE	Hospitalist Physician	$0	$2.6M
Eyes On Lincoln	NE	Optometrist	$0	$2.6M

Jennifer Elliott — Billing Profile & Reimbursement Data

Sign up for Jennifer Elliott — Billing Profile & Reimbursement Data policy alerts

Jennifer Elliott — Billing Profile & Reimbursement Data

Sign up for Jennifer Elliott — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References